Related references
Note: Only part of the references are listed.Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study
Rosaria Greco et al.
CEPHALALGIA (2021)
Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine
Adriana Della Pietra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The endocannabinoid system - current implications for drug development
C. J. Fowler
JOURNAL OF INTERNAL MEDICINE (2021)
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine
Rosaria Greco et al.
NEUROBIOLOGY OF DISEASE (2021)
Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
Rosaria Greco et al.
CELLS (2021)
Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache
Caroline M. Kopruszinski et al.
CEPHALALGIA (2020)
Short- and Long-Term Effects of Cannabis on Headache and Migraine
Carrie Cuttler et al.
JOURNAL OF PAIN (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study
Rosaria Greco et al.
NEUROBIOLOGY OF DISEASE (2020)
Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Mikiei Tanaka et al.
FRONTIERS IN NEUROLOGY (2020)
Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study
Laura Papetti et al.
PAIN RESEARCH & MANAGEMENT (2020)
The Role of the Cannabinoid System in Opioid Analgesia and Tolerance
Ercan Ozdemir
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications
John Wolf et al.
CURRENT PAIN AND HEADACHE REPORTS (2020)
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention
J. Schoenen et al.
REVUE NEUROLOGIQUE (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief
Francesca Gado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The endocannabinoid system in migraine: from bench to pharmacy and back
Cristina Tassorelli et al.
CURRENT OPINION IN NEUROLOGY (2019)
Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect
Peer Tfelt-Hansen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
Francesca Gado et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
Elio Clemente Agostoni et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Opioid and Endocannabinoid System in Orofacial Pain
M. Zubrzycki et al.
PHYSIOLOGICAL RESEARCH (2019)
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
Jie Wu
ACTA PHARMACOLOGICA SINICA (2019)
The endocannabinoid system: Novel targets for treating cancer induced bone pain
Jia Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Anti-migraine effect of Delta(9)-tetrahydrocannabinol in the female rat
Ram Kandasamy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis
Jakub Mlost et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
Aitziber Mendiguren et al.
LIFE SCIENCES (2018)
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action
Till Sprenger et al.
NEUROTHERAPEUTICS (2018)
Endocannabinoid System and Migraine Pain: An Update
Rosaria Greco et al.
FRONTIERS IN NEUROSCIENCE (2018)
Emerging Role of (Endo)Cannabinoids in Migraine
Pinja Leimuranta et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Maria S. Aymerich et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study
Domenico Chirchiglia et al.
FRONTIERS IN NEUROLOGY (2018)
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A. Slivicki et al.
BIOLOGICAL PSYCHIATRY (2018)
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine?
Rosaria Greco et al.
CEPHALALGIA (2018)
TGN-1412 and BIA-2474 Trials with Tragic End: Lessons Learnt To Make Clinical Trials Safer
Rimple Jeet Kaur et al.
REVIEWS ON RECENT CLINICAL TRIALS (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache
Rodrigo Noseda et al.
HEADACHE (2017)
The cannabinoid system and pain
Stephen G. Woodhams et al.
NEUROPHARMACOLOGY (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Plasma levels of the endocannabinoid anandamide, related N-acylethanolamines and linoleic acid-derived oxylipins in patients with migraine
Sandra Gouveia-Figueira et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2017)
Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats
Marek Zubrzycki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
Gillian M. Keating
DRUGS (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
Linda Gabrielsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat
Gabor Nagy-Grocz et al.
CEPHALALGIA (2016)
TRPV1-FAAH-COX: The Couples Game in Pain Treatment
Francesca Aiello et al.
CHEMMEDCHEM (2016)
Fatty acids, endocannabinoids and inflammation
Renger Witkamp
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis
Nicola S. Orefice et al.
NEUROTHERAPEUTICS (2016)
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
Danielle N. Rhyne et al.
PHARMACOTHERAPY (2016)
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management
Natalia Malek et al.
FRONTIERS IN PHARMACOLOGY (2016)
Effects of peripheral FAAH blockade on NTG-induced hyperalgesiaevaluation of URB937 in an animal model of migraine
R. Greco et al.
CEPHALALGIA (2015)
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice
Chihiro Nozaki et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage
Oscar Sasso et al.
FASEB JOURNAL (2015)
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo et al.
NEUROTHERAPEUTICS (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis
Natalia Malek et al.
PAIN (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia
Benjamin K. Lau et al.
CURRENT OPINION IN NEUROBIOLOGY (2014)
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
Rosaria Greco et al.
JOURNAL OF HEADACHE AND PAIN (2014)
Advances in the discovery of N-acylethanolamine acid amidase inhibitors
Tiziano Bandiera et al.
PHARMACOLOGICAL RESEARCH (2014)
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Mireille Alhouayek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Non-psychotropic analgesic drugs from the endocannabinoid system: Magic bullet or multiple-target strategies?
Katarzyna Starowicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and Triptan Receptors: Implications in Migraine
Simon Akerman et al.
JOURNAL OF NEUROSCIENCE (2013)
Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as dual-target analgesics
Sabatino Maione et al.
PHARMACOLOGICAL RESEARCH (2013)
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids
Adrianne R. Wilson-Poe et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Redundancy of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
Fabiana Piscitelli et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients
Bart J. Van der Schueren et al.
HEADACHE (2012)
Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment
Armando Perrotta et al.
HEADACHE (2012)
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
Luigi Alberto Pini et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin
Jessica Marie Spradley et al.
NEUROPHARMACOLOGY (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
The endocannabinoid system: an overview
Natalia Battista et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2012)
Effects of anandamide in migraine: data from an animal model
Rosaria Greco et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin
Matthias A. Engel et al.
NEUROPEPTIDES (2011)
Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat
R. Greco et al.
CEPHALALGIA (2010)
Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
V. Marzo et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
N-acylethanolamines, anandamide and food intake
Harald S. Hansen et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Variations in the cannabinoid receptor 1 gene predispose to migraine
Gabriella Juhasz et al.
NEUROSCIENCE LETTERS (2009)
Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano et al.
PHYSIOLOGICAL REVIEWS (2009)
Prophylactic Drugs and Cytokine and Leptin Levels in Children With Migraine
Tugba Hirfanoglu et al.
PEDIATRIC NEUROLOGY (2009)
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
Jonathan Z. Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
The endocannabinoid system and energy metabolism
L. Bellocchio et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Degradation of endocannabinoids in chronic migraine and medication overuse headache
L. M. Cupini et al.
NEUROBIOLOGY OF DISEASE (2008)
Microglia produce and hydrolyze palmitoylethanolamide
Giulio G. Muccioli et al.
NEUROPHARMACOLOGY (2008)
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels
Cristiana Rossi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Δ9-Tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed
J. D. Wilkinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The complications of promiscuity: endocannabinoid action and metabolism
S. P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain
Margarita Suardiaz et al.
PAIN (2007)
Endocannabinoids in chronic migraine: CSF findings suggest a system failure
Paola Sarchielli et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): Effect of cAMP, cannabinoid CB, receptors and endovanilloids
Luciano De Petrocellis et al.
EXPERIMENTAL CELL RESEARCH (2007)
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors
S. Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons
Simon Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The N-acylethanolamine-hydrolyzing acid amidase (NAAA)
Kazuhito Tsuboi et al.
CHEMISTRY & BIODIVERSITY (2007)
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α
Jesse LoVerme et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs
LM Cupini et al.
CEPHALALGIA (2006)
Cannabinoid receptors and endocannabinoids: Evidence for new players
Ken Mackie et al.
AAPS JOURNAL (2006)
The search for the palmitoylethanolamide receptor
J LoVerme et al.
LIFE SCIENCES (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Molecular and cellular basis of cannabinoid and opioid interactions
D Viganò et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions:: Review of the available pre-clinical data, and first human studies
NA Darmani et al.
NEUROPHARMACOLOGY (2005)
Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1
XB Wang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide
TJ Price et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Synergistic interactions between cannabinoid and opioid analgesics
DL Cichewicz
LIFE SCIENCES (2004)
Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS
S Moreno et al.
NEUROSCIENCE (2004)
Endomorphin-1 causes synovial hypoaemia in rat knee joints via a capsaicin-sensitive neural pathway
AK Barin et al.
NEUROSCIENCE LETTERS (2003)
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
S González et al.
BRAIN RESEARCH (2002)
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
GL Gerdeman et al.
NATURE NEUROSCIENCE (2002)
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
J Chemin et al.
EMBO JOURNAL (2001)
Lipoxygenases and their involvement in programmed cell death
M Maccarrone et al.
CELL DEATH AND DIFFERENTIATION (2001)
Functional interaction between opioid and cannabinoid receptors in drug self-administration
M Navarro et al.
JOURNAL OF NEUROSCIENCE (2001)
The endocannabinoid system as a target for therapeutic drugs
D Piomelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor -: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
T Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
